Neubase Therapeutics Inc Stock News

The BioNTech/Pfizer team has launched its Phase 2/3 clinical trial in the USA and internationally for its COVID-19 vaccine on July 27, 2020, after excellent Phase 1/2 clinical trial results.

Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the closing of $360M in additional

We still expect the economy to remain on a recovery path but it will not be as quick as earlier assumed.

The Past Week, In A Nutshell What Happened: Stocks closed the week practically unchanged after mixed reactions to a slew of blow-out earnings results. Remember This: “...

The deal appears to price the vaccine at less than $10.50 a dose.

Moderna Inc (NASDAQ: MRNA), which commenced a late-stage trial of its mRNA vaccine, codenamed mRNA-1273, against SARS-CoV-2 earlier in the week, has been reportedly targeted...

Shares of Moderna Inc. undefined were down 0.2% in trading on Thursday after the market closed when it said a board member had resigned to avoid the...

Moderna stock has had one of the best times of any stock in 2020, but the future is growing more uncertain for the company as the COVID-19 vaccine continues to undergo trials.

Some say never bring up politics. Looking ahead to August on Wall Street, though, it’s hard to avoid. Entering the month, the big question is whether Congress and the White...

The stocks making the biggest moves in premarket trading include Boeing, GE, GM, Spotify, Eastman Kodak, and more.

The Wednesday wait is on, with two key things in focus: The Fed meeting that wraps up after lunch and today’s congressional testimony from tech executives where they’...

Moderna has got nearly $1B in support from the U.S. government so far to support the development of the COVID-19 vaccine, MRNA is up.

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...

The coronavirus illness COVID-19 claimed another 1,100 lives in the U.S. in a single day to push the death toll above 145,000 on Saturday, marking a fourth...

Analysts expect NeuBase Therapeutics (NASDAQ:NBSE) to post earnings per share (EPS) of ($0.24) for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates fo